Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Antipsychotic Treatment Discontinuation

Research Leaders

8 sponsors active, led by Fundación Marques de Valdecilla

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Completed5
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05473741Completed

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

NCT05986409Not ApplicableCompletedPrimary

Indoor Artificial Light at Night and the Relapse Risk of Schizophrenia

NCT03019887Not ApplicableCompletedPrimary

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

NCT03090490Not ApplicableUnknown

10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

NCT03558529CompletedPrimary

Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse

NCT02220504Not ApplicableCompleted

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Showing all 6 trials

Research Network

Common Treatments

  • Antipsychotic Treatment Discontinuation2
  • Second Generation Longacting Injectable Antipsychotic Medications1
  • Light Cover1
  • Maintenance Antipsychotic Treatment1
  • Maintenance Treatment Discontinuation1

Active Sponsors

  • Fundación Marques de Valdecilla2
  • Instituto de Investigación Marqués de Valdecilla2
  • Centro de Investigación Biomédica en Red de Salud Mental2
  • Centre for Addiction and Mental Health1
  • Janssen Inc.1

Top Investigators

Related Conditions

  • Schizophrenia4
  • Schizophrenia Spectrum And Other Psychotic Disorders2
  • Schizo Affective Disorder1
  • Psychotic Disorders1
  • Light Pollution1

Activity Timeline